Afficher la notice abrégée

dc.contributor.editorWat, Dennis
dc.contributor.editorNazareth, Dilip
dc.date.accessioned2021-04-20T16:19:02Z
dc.date.available2021-04-20T16:19:02Z
dc.date.issued2020
dc.identifierONIX_20210420_9781789841466_2949
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/67589
dc.description.abstractCystic Fibrosis - Heterogeneity and Personalized Treatment provides the latest research and clinical evidence for clinicians, scientists and researchers involved in the care of patients with cystic fibrosis (CF). This book outlines the burden of the CF microbiome, utilisation of CF registries to impact future care, the sequelae of hepatobiliary complication, the use of upcoming technologies to provide patient-centred care, and provides an overview of cystic fibrosis transmembrane regulator (CFTR) modulators. Looking after patients with CF is highly rewarding, allowing those of us to combine our dedication and problem-solving skills to create a personalized approach. This book is invaluable for those involved in the care of CF patients.
dc.languageEnglish
dc.subject.classificationthema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJK Dermatologyen_US
dc.subject.otherRespiratory medicine
dc.titleCystic Fibrosis
dc.title.alternativeHeterogeneity and Personalized Treatment
dc.typebook
oapen.identifier.doi10.5772/intechopen.77691
oapen.relation.isPublishedBy78a36484-2c0c-47cb-ad67-2b9f5cd4a8f6
oapen.relation.isbn9781789841466
oapen.relation.isbn9781789841459
oapen.relation.isbn9781838809683
oapen.imprintIntechOpen
oapen.pages136


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

https://creativecommons.org/licenses/by/3.0/
Excepté là où spécifié autrement, la license de ce document est décrite en tant que https://creativecommons.org/licenses/by/3.0/